Home Overview Press Room Blog Publications For Students about us
Search

Medical Gene Transfer : Displaying 86-95 of 142


Gene Therapy to Treat Cancer for First TimePress Trust of IndiaJune 19th, 2008Doctors have treated a cancer patient by injecting him with billions of his own genetically-modified immune cells
Gene Fears by Doping BodyEdinburgh Evening NewsJune 12th, 2008The World Anti-Doping Agency has called for increased awareness of the dangers of gene doping, which is thought to be the next big performance-enhancing threat in world sport.
Protecting research subjects from a broken system by Marcy DarnovskyBiopolitical TimesApril 8th, 2008Until conflicts of interest are eliminated, research subjects will never be safe.
Eight Years after Jesse’s Death, Are Human Research Subjects Any Safer?by Paul Gelsinger and Adil E. ShamooHastings Center ReportApril 4th, 2008Many things stand in the way of better protection, but perhaps the greatest obstacle is the lack of adequate federal oversight.
The Future: Think performance enhancers are a problem now?Welcome to the era of the genetically engineered superathleteby David EpsteinSports IllustratedMarch 11th, 2008If athletes develop ways to alter their genes, the very blueprints for their own muscles, there may be no test of blood or urine that can pick that up.
Nature Biotech reports CGS skepticism about IRBs-for-hireby Marcy DarnovskyBiopolitical TimesFebruary 5th, 2008An article published in Nature Biotech last September quotes CGS's Osagie Obasogie's concerns about private IRBs.
The New Republic Asks Whether Baseball is Already Losing the Next Doping Battle by Osagie ObasogieBiopolitical TimesJanuary 29th, 2008The New Republic blog have shifted the focus of baseball's scrutiny from past to future by asking whether the sport is already losing the next big doping battle.
Boy gets leukaemia after gene treatment to cure ‘bubble baby syndrome’The Times (UK)December 19th, 2007One of the first children in Britain to receive gene therapy for an immune system disorder has developed leukaemia as a result of his treatment.
Death in gene therapy trial raises questions about private IRBsby Heidi LedfordNature BiotechnologySeptember 30th, 2007Researchers are increasingly turning to private, for-profit IRBs that promise quick turnaround times, especially for company-sponsored trials.
More Public Accountability Needed in Gene Therapy Death, Says Public Interest Group Center for Genetics and Society Calls for Moratorium on Enrolling Some PatientsSeptember 17th, 2007The Recombinant DNA Advisory Committee met today to discuss a recent death in an experiment, but offered no answers to important ethical questions raised by the tragedy.
Displaying 86-95 of 142  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760